CARBOCAINE Description
(mepivacaine Hydrochloride Injection, USP)
11 DESCRIPTION
CARBOCAINE contains mepivacaine hydrochloride, an amide local anesthetic, as the active pharmaceutical ingredient. The route of administration for CARBOCAINE is by injection, for local infiltration, peripheral nerve block, and caudal and lumbar epidural blocks. Multiple-dose vials contain methylparaben [see Warnings and Precautions (5.3)].
Mepivacaine hydrochloride is 2-piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl, monohydrochloride. It is a white crystalline odorless powder, soluble in water, but very resistant to both acid and alkaline hydrolysis. It has the following structural formula:
C15H22N2O • HCl
CARBOCAINE (mepivacaine hydrochloride) is a clear and colorless sterile isotonic solution. Each mL of single-dose vial contains 10 mg, 15 mg or 20 mg of mepivacaine hydrochloride (equivalent to 8.71 mg, 13.07 mg, or 17.42 mg of mepivacaine, respectively) with the detailed composition shown in the table. Each mL of multiple-dose vial contains 10 mg or 20 mg of mepivacaine hydrochloride (equivalent to 8.71 mg or 17.42 mg of mepivacaine, respectively) with the detailed composition shown in the table.
| |||||
Composition of Available Solutions* | |||||
1% Single-Dose 30 mL Vial mg/mL | 1% Multiple-Dose 50 mL Vial mg/mL | 1.5% Single-Dose 30 mL Vial mg/mL | 2% Single-Dose 20 mL Vial mg/mL | 2% Multiple-Dose 50 mL Vial mg/mL | |
Mepivacaine | | | | |
20 |
Sodium chloride | 6.6 | 7 | 5.6 | 4.6 | 5 |
Potassium chloride | 0.3 | 0.3 | 0.3 | ||
Calcium chloride | 0.33 | 0.33 | 0.33 | ||
Methylparaben | 1 | 1 | |||
The specific gravity of CARBOCAINE 1% at 25 °C is 1.007 for the single-dose vials and 1.008 for the multiple-dose vials. The specific gravity of CARBOCAINE 1.5% and 2% at 25 °C is 1.008.
Find CARBOCAINE medical information:
Find CARBOCAINE medical information:
CARBOCAINE Quick Finder
Health Professional Information
Description
11 DESCRIPTION
CARBOCAINE contains mepivacaine hydrochloride, an amide local anesthetic, as the active pharmaceutical ingredient. The route of administration for CARBOCAINE is by injection, for local infiltration, peripheral nerve block, and caudal and lumbar epidural blocks. Multiple-dose vials contain methylparaben [see Warnings and Precautions (5.3)].
Mepivacaine hydrochloride is 2-piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl, monohydrochloride. It is a white crystalline odorless powder, soluble in water, but very resistant to both acid and alkaline hydrolysis. It has the following structural formula:
C15H22N2O • HCl
CARBOCAINE (mepivacaine hydrochloride) is a clear and colorless sterile isotonic solution. Each mL of single-dose vial contains 10 mg, 15 mg or 20 mg of mepivacaine hydrochloride (equivalent to 8.71 mg, 13.07 mg, or 17.42 mg of mepivacaine, respectively) with the detailed composition shown in the table. Each mL of multiple-dose vial contains 10 mg or 20 mg of mepivacaine hydrochloride (equivalent to 8.71 mg or 17.42 mg of mepivacaine, respectively) with the detailed composition shown in the table.
| |||||
Composition of Available Solutions* | |||||
1% Single-Dose 30 mL Vial mg/mL | 1% Multiple-Dose 50 mL Vial mg/mL | 1.5% Single-Dose 30 mL Vial mg/mL | 2% Single-Dose 20 mL Vial mg/mL | 2% Multiple-Dose 50 mL Vial mg/mL | |
Mepivacaine | | | | |
20 |
Sodium chloride | 6.6 | 7 | 5.6 | 4.6 | 5 |
Potassium chloride | 0.3 | 0.3 | 0.3 | ||
Calcium chloride | 0.33 | 0.33 | 0.33 | ||
Methylparaben | 1 | 1 | |||
The specific gravity of CARBOCAINE 1% at 25 °C is 1.007 for the single-dose vials and 1.008 for the multiple-dose vials. The specific gravity of CARBOCAINE 1.5% and 2% at 25 °C is 1.008.
Health Professional Information
{{section_name_patient}}
{{section_body_html_patient}}
Resources
Didn’t find what you were looking for? Contact us.
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5Pm ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Report Adverse Event
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.